Teng-da XU, Lu GUO, Shao-rong SU, Ying DU, Ying WANG, Hai-tao WANG, Zhen-jie WANG. Management Effects of Smart Health Internet of Things System on the Therapeutic Lifestyle Changes in Patients with Dyslipidemia[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(1): 42-47. doi: 10.3969/j.issn.1674-9081.2018.01.009
Citation: Teng-da XU, Lu GUO, Shao-rong SU, Ying DU, Ying WANG, Hai-tao WANG, Zhen-jie WANG. Management Effects of Smart Health Internet of Things System on the Therapeutic Lifestyle Changes in Patients with Dyslipidemia[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(1): 42-47. doi: 10.3969/j.issn.1674-9081.2018.01.009

Management Effects of Smart Health Internet of Things System on the Therapeutic Lifestyle Changes in Patients with Dyslipidemia

doi: 10.3969/j.issn.1674-9081.2018.01.009
More Information
  • Corresponding author: WANG Zhen-jie Tel:010-69159901, E-mail:wangzhenjie2002@aliyun.com
  • Received Date: 2017-07-07
  • Publish Date: 2018-01-30
  •   Objective   This study aimed to explore the feasibility and effectiveness of Smart Health Internet of Things System in managing therapeutic lifestyle changes(TLC)for the treatment of dyslipidemia.   Methods   Fifty-two patients with dyslipidemia were recruited in a three-month TLC program. Smart Health Internet of Things System (a wearable home-monitoring smart APP) was adopted to interfere the management of lifestyle. Parameters that were observed and investigated included behavioral habits (diet, exercise) and physical examination.   Results   With the intervention of Smart Health Internet of Things System, the parameters of the subjects' behavioral habits achieved total beneficial rates ranging from 5.5% to 49.9%, and the parameters of physiological examination achieved total beneficial rates ranging from -6.9% to 63.6%. The body mass index, waistline, hipline, waist-to-hip ratio, blood pressure, triglyceride, total cholesterol, and fasting plasma glucose all showed significant decreases after the TLC program(all P < 0.05).   Conclusions   Smart Health Internet of Things System has fairlygood feasibility and effectiveness on managing the TLC of dyslipidemic patients.
  • loading
  • [1] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志, 2007, 35:390-419. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhxxgb200705003
    [2] 北京市体检质量控制和改进中心.北京市2013年度体检统计资料报告[R].北京, 2014: 30-35.
    [3] National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) final report[J]. Circulation, 2002, 106:3143-3421. doi:  10.1161/circ.106.25.3143
    [4] 张欣颖, 王伯莹.治疗性生活方式改变对冠心病合并高血脂症患者降脂作用的研究进展[J].中国实用护理杂志, 2008, 2:75-77. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=syhlzz200806042
    [5] 刘思彤, 武韬, 毛宏辉.治疗性生活方式改变对血脂异常患者的效果观察[J].北京医学, 2012, 34:75-77. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bjyx201211006
    [6] 赵珺瑜, 李红.血脂异常患者治疗性生活方式改变的研究进展[J].护理学杂志, 2015, 30:106-109. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=hlxzz201501036
    [7] 杨芳, 刘璐, 郑霞飞, 等.慢性病患者治疗性生活方式改变的概述及干预研究进展[J].护理学报, 2016, 23:35-38. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=nfhlxb201607010
    [8] Borgia E. The Internet of Things vision:key feature, applications and open issues[J]. Computer Communications, 2014, 54:1-31. doi:  10.1016/j.comcom.2014.09.008
    [9] Santos A, Macedo J, Costa A, et al. Internet of Things and smart objects for M-health monitoring and control[J]. Procedia Technol, 2014, 16:1351-1360. doi:  10.1016/j.protcy.2014.10.152
    [10] Cotter AP, Durant N, Agne AA, et al. Internet interventions to support lifestyle modification for diabetes management:a systematic review of the evidence[J]. J Diabetes Complications, 2014, 28:243-251. doi:  10.1016/j.jdiacomp.2013.07.003
    [11] Byington RP, Jukema JW, Salonen JT, et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program[J]. Circulation, 1995, 92:2419-2425. doi:  10.1161/01.CIR.92.9.2419
    [12] Lenz TL. Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults[J]. J Am Pharm Assoc, 2005, 45:492-502. doi:  10.1331/1544345054475595
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(4)

    Article Metrics

    Article views (166) PDF downloads(115) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return